Local Treatments of Oligometastatic and Oligoprogressive NSCLC Should Not Become the Standard of Care. Macbeth F, Treasure T. J Thorac Oncol 2023;18:981-985.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Macbeth F, Treasure T. Local Treatments of Oligometastatic and Oligoprogressive NSCLC Should Not Become the Standard of Care. J Thorac Oncol 2023;18:981-985.
PMID: 37479328